靶向HER2增强Lewis肺癌细胞放射敏感性并降低转移潜能
该临床前研究探讨EGFR/HER2激活与MMP-9介导的放射抵抗及侵袭性的关联。LLC细胞经厄洛替尼或阿法替尼处理后接受亚致死剂量辐射,检测EGFR/HER2磷酸化及MMP-9表达,并通过克隆形成实验和Matrigel包被Boyden小室实验评估放射敏感性与侵袭性。结果显示阿法替尼较厄洛替尼更有效增强放射敏感性并降低侵袭性,且阿法替尼在体内消除了辐射诱导的肺转移;HER2敲低细胞经辐射后生长受抑。
要点
- 阿法替尼较厄洛替尼更有效增强LLC细胞放射敏感性并降低侵袭性。
- 阿法替尼在体内消除了辐射诱导的肺转移。
- HER2敲低联合辐射可抑制LLC细胞生长。
核心结论
- 阿法替尼双抑制辐射激活的EGFR和HER2信号可抑制受照LLC细胞的增殖与侵袭,药理学或遗传学抑制HER2在体内均增强放射敏感性并减少转移播散。
研究设计与样本
- LLC细胞经厄洛替尼或阿法替尼处理后再接受亚致死剂量辐射,检测EGFR/HER2磷酸化及MMP-9表达。
- 克隆形成实验测定激酶抑制剂是否使LLC细胞对辐射增敏,Matrigel包被Boyden小室实验评估细胞侵袭性。
- 野生型LLC细胞或HER2敲低突变细胞形成的肿瘤接受辐射以诱导肺转移。
主要发现
- 阿法替尼较厄洛替尼更有效使LLC细胞对辐射增敏并降低侵袭性,同时抑制EGFR、HER2、Akt、ERK和p38磷酸化并下调MMP-9。
- 阿法替尼在体内消除了辐射诱导的肺转移。
- LLC HER2敲低细胞经辐射处理后出现生长抑制。
临床怎么用
- 在LLC模型中,阿法替尼双靶抑制EGFR/HER2较厄洛替尼更有效增强放射敏感性并减少辐射诱导的肺转移。
- HER2药理学或遗传学抑制在体内均增强放射敏感性并减少转移播散,提示HER2在放射抵抗和转移潜能中起关键作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sublethal radiation induces matrix metalloproteinase 9 (MMP-9)-mediated radioresistance in Lewis lung carcinoma (LLC) cells and their metastatic dissemination. We aim to determine if EGFR/HER2 activation associates with MMP-9-mediated radioresistance and invasiveness in irradiated LLC cells. METHODS: LLC cells were treated with erlotinib or afatinib followed by sublethal radiation. After irradiation, we examined the phosphorylation of EGFR/HER2 and MMP-9 expression. Colony formation assay determined if the kinase inhibitors sensitize LLC cells to radiation. Matrigel-coated Boyden chamber assay assessed cellular invasiveness. Resulting tumors of wild-type LLC cells or HER2 knock-down mutant cells were irradiated to induce pulmonary metastases. RESULTS: Afatinib more effectively sensitized LLC cells to radiation and decreased invasiveness by inhibiting phosphorylation of EGFR, HER2, Akt, ERK, and p38, and down-regulating MMP-9 when compared to erlotinib. Afatinib abolished radiation-induced lung metastases in vivo. Furthermore, LLC HER2 knock-down cells treated with radiation had growth inhibition. CONCLUSION: Dual inhibition of radiation-activated EGFR and HER2 signaling by afatinib suppressed the proliferation and invasion of irradiated LLC cells. Increased radiosensitivity and decreased metastatic dissemination were observed by pharmacological or genetic HER2 inhibition in vivo. These findings indicate that HER2 plays a pivotal role in enhancing radioresistance and reducing metastatic potential of LLC cells.
引用
- Tien Y, Tsai CL, Hou WH, et al. Targeting human epidermal growth factor receptor 2 enhances radiosensitivity and reduces the metastatic potential of Lewis lung carcinoma cells. Radiat Oncol. 2020. PMID: 32143669. doi:10.1186/s13014-020-01493-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。